ARTICLE | Company News
CIBA files Rescula for U.S. and EU approval
March 3, 2000 8:00 AM UTC
CIBA Vision completed marketing filings in the U.S. and EU for Rescula unoprostone isopropyl ophthalmic solution to treat glaucoma. CIBA licensed Rescula from Ueno Fine Chemicals (Tokyo, Japan). ...